The goal of this clinical research study is to learn the highest safe doses of the
combination of Doxil (liposomal doxorubicin), Avastin (bevacizumab), and Torisel
(Temsirolimus) that can be given to patients with advanced cancer that has spread or is
unable to be surgically removed. The safety and effectiveness of this combination of drugs
will also be studied.